Skip to main content
. 2024 Jun 21;26(2):80–86. doi: 10.1016/j.ccrj.2024.03.001

Table 1.

Primary and secondary outcomes.

Primary outcome
Occurrence of moderate or severe AKI (KDIGO stage 2 or 3) within 72 h after surgery
Secondary outcomes
  • 1.

    Adherence to the KDIGO bundle5

  • 2.

    Occurrence and severity of any stage of acute kidney injury within 3 days after surgery

  • 3.

    Change in biomarker values during 12 h after initial measurement of [TIMP2]∗[IGFBP7]

  • 4.

    Free-days of mechanical organ support through to day 3

  • 5.

    Free-days of vasopressors through day 3

  • 6.

    Need of RRT at day 30 and 90

  • 7.

    Duration of RRT at day 30 and 90

  • 8.

    Renal recovery at day 90

  • 9.

    30-day and 90-day mortality

  • 10.

    ICU length-of-stay and Hospital length-of-stay

  • 11.

    Major adverse kidney events (MAKE90) (defined as the composite of death, use of RRT and persistent renal dysfunction (defined as serum creatinine ≥2x to baseline value at hospital discharge)) at day 90